Huiyi Lv

Prof. Huiyi Lv


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
LCLi-Chun Cheng
Li-Chun Cheng
YJYan Jiang
Yan Jiang
YXYu Xie
Yu Xie
LQLu-Lu Qiu
Lu-Lu Qiu
QYQing Yang
Qing Yang
HLHuiyi Lv
Huiyi Lv
Novel amphiphilic folic acid-cholesterol-chitosan micelles for paclitaxel delivery Novel amphiphilic folic acid-cholesterol-chitosan micelles for paclitaxel delivery

1 February 2020 in Talanta
Verified
Journal Article
Closed access
JWJuan Wei
Juan Wei
LCLichun Cheng
Lichun Cheng
JLJingmin Li
Jingmin Li
YLYuanchang Liu
Yuanchang Liu
SYShuqing Yin
Shuqing Yin
CLChong Liu
Chong Liu

13 June 2017 in Hereditary Cancer in Clinical Practice
Verified
Journal Article
Open access
PDF file
YJYan Jiang
Yan Jiang
CZChen-Yang Zhao
Chen-Yang Zhao
LCLi-Chun Cheng
Li-Chun Cheng
BXBing Xu
Bing Xu
HLHuiyi Lv
Huiyi Lv
Adenosine diphosphate (ADP)-ribosylation factor-like tumour suppressor gene 1(ARLTS1) might be associated with an increased risk of several types of familial cancers. However, previous studies have shown that cancer susceptibility is not completely consistent with ARLTS1 polymorphisms, and the precise mechanism remains unknown. Therefore, we conducted a meta-analysis of case-control studies by searching the PubMed, Embase, OVID, Science Direct and Chinese National Knowledge Infrastructure (CNKI) databases. In total, 12 studies met the inclusion criteria and were included in this meta-analysis. Statistical analyses were performed using STATA 11.0 software. Overall, the Cys148Arg T > C variant significantly increased cancer risk (CC vs. TT: OR = 1.27, 95% CI = 1.15–1.41, P < 0.05). The stratification indicated that the Cys148Arg variant is significantly associated with sporadic cancer (CC vs. TT: OR = 1.36, 95% CI = 1.18–1.55) and familial cancer (CC vs. TT: OR = 1.26, 95% CI = 1.12–1.43). Trp149Stop, Pro131Leu, Ser99Ser and Leu132Leu were not correlated with cancer susceptibility. Based on these results, we demonstrated that the ARLTS1 Cys148Arg polymorphism is associated with an increased risk of sporadic cancer and familial cancer, and there were no associations between the other four SNPs (i.e., Trp149Stop, Pro131Leu, Ser99Ser and Leu132Leu) and cancer risk.